Financials
| Annual Financial Report | Feb. 02, 2026 |
| Interim 2025 Results | Jun. 25, 2025 |
| Annual Report and Financial Statements for the year ended 30 September 2024 | Jan. 31, 2025 |
| Annual Financial Report | Jan. 31, 2025 |
| Annual Financial Report | Jan. 31, 2025 |
| Interim Results | Jun. 11, 2024 |
| Full Year Results | Jan. 31, 2024 |
Proxies
| Result of Annual General Meeting | Mar. 03, 2026 |
| Result of Annual General Meeting | Mar. 05, 2025 |
| AGM Statement | Feb. 10, 2025 |
| Proxy Form | Feb. 07, 2025 |
| Notice of AGM | Feb. 07, 2025 |
| Notice of AGM | Feb. 26, 2024 |
| Result of Annual General Meeting | Mar. 15, 2023 |
Ownership Update
| Director/PDMR Shareholding | Jun. 18, 2024 |
| Director/PDMR Shareholding | Jun. 17, 2024 |
| Director/PDMR Shareholding | Jun. 14, 2024 |
| Standard form for notification of major holdings | Nov. 30, 2023 |
Announcements
| First Tannable A4-Sized Skin Achieved | Mar. 10, 2026 |
| Update on Proposed Equity Fundraise | Feb. 27, 2026 |
| Annual Financial Report - Correction | Feb. 03, 2026 |
| KERATO LIMITED SIGNS WITH QUEBEC PSO GRANT | Jan. 19, 2026 |
| Result of General Meeting | Dec. 17, 2025 |
| 3D Bio-Tissues Signs Supply Agreement with SeaWith | Dec. 16, 2025 |
| Changes to timetable for proposed Equity Fundraise | Dec. 15, 2025 |
Prospectuses
| Prospectus | Mar. 06, 2025 |
| Prospectus dated 27 April 2022 | Apr. 27, 2022 |
| BSF Enterprise Plc - Single prospectus | Apr. 27, 2022 |
| Prospectus | Jul. 19, 2019 |